Share to: share facebook share twitter share wa share telegram print page

COVID-19 vaccination in mainland China

COVID-19 vaccination in mainland China
COVID-19 vaccine doses administered in mainland China.
Date22 July 2020 (2020-07-22) – 13 April 2023 (2023-04-13)
Location China
CauseCOVID-19 pandemic in mainland China
TargetImmunization against COVID-19
Organized byJoint Prevention and Control Mechanism in Response to the COVID-19 Pandemic of the State Council [zh]
(headquartered at National Health Commission)
Participants3,491,077,000[1] (total doses administered)
Outcome1,310,292,000[1] (total vaccinated)
1,276,760,000[1] (fully vaccinated)
Part of a series on the
COVID-19 pandemic
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Timeline
2019
2020
2021
2022
2023
Locations
By country and territory
By conveyance
International response
National responses
Medical response
Vaccines
Current vaccines
Variants
Variants of concern
Other variants
Economic impact and recession
By country
By sport
Impacts
Society
virus icon COVID-19 portal


COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region.

As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the population has received a booster dose.[2]

Administration

In June 2020, the Sinopharm BIBP vaccine (BBIBP-CorV) was authorized for emergency use in China. On July 22, Chinese authorities started the emergency use of COVID-19 vaccines.[3]

On December 15, 2020, the COVID-19 vaccination for people under high risk started in China.[4] On December 19, 2020, the National Health Commission (NHC) said that there has been 1 million doses of COVID-19 vaccine administered in China as of the day, and no serious adverse reactions were observed.[5]

On December 31, 2020, NHC announced that the Sinopharm BIBP vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of COVID-19 vaccine has been administered in China.[6] At the same time, NHC declares that COVID-19 vaccination is free to Chinese citizens.[7]

On January 27, 2021, NHC said that the vaccination is being carried out in order, and there has been 22.767 million doses of COVID-19 vaccine administered in China as of January 26.[8]

On March 1, 2021, Zhong Nanshan said that the vaccination rate of COVID-19 vaccine in China was currently 3.56%, and the Chinese Center for Disease Control and Prevention hoped the rate reach 40% by the end of June 2021.[9]

Since late March 2021, the authorities has accelerated the promotion of free COVID-19 vaccination for the whole population.[4] On March 22, 2021, Sun Chunlan, the Vice Premier of the State Council, stated that COVID-19 vaccination in China should be accelerated and the vaccination rate should be increased.[10] On March 24, 2021, NHC announced that the number doses of COVID-19 vaccine administered will be daily reported on its website and social media account since that day.[11] On March 29, 2021, NHC released the first version of the COVID-19 Vaccine Technology Guide.[12]

On April 21, 2021, NHC stated that more than 200 million doses of COVID-19 vaccine has been administered in China, and 80% of doctors and nurses has been vaccinated.[13]

On May 14, 2021, NHC restated that the COVID-19 administration progress should be accelerated due to the proportion of mutated SARS-CoV-2 and the re-appearance of local cases.[14]

On June 19, 2021, NHC announced that more than 1.01489 billion doses of COVID-19 vaccine has been administered in China.[15]

While public authorities have mandated lockdowns and mandatory mass testing for areas with infection, there has not been any rule to making vaccination mandatory. Some facilities within China have made vaccination mandatory for entry, including things like movie theatres, fitness centres, internet bars, museums and libraries.[16]

In July 2022, according to official figures, while 89% had received 2 doses, only 56% of eligible people had received a booster dose. Furthermore, this was even lower among vulnerable elderly age groups, with only 19.7% of people over the age of 80 having received a booster dose. According to BBC reporting, this may have been attributed to public confidence in the ability of authorities to control outbreaks, the narrative presented by public authorities within China that the virus was mainly an overseas problem as well as some doctors within China who warned vulnerable people of the health risks of the vaccine.[16]

Doses of COVID-19 vaccine administrated in mainland China
As of Doses administrated
(in million)		 References
Dec 19
(2020)		 >1 [5]
Dec 31
(2020)		 >3 [6]
Jan 27
(2021)		 22.767 [8]
Feb 9 40.52 [17]
Mar 15 64.98 [18]
Mar 28 102.417 [DR 1]
Apr 21 204.191 [DR 2]
May 7 308.226 [DR 3]
May 16 406.938 [DR 4]
May 23 510.858 [DR 5]
May 28 602.991 [DR 6]
Jun 2 704.826 [DR 7]
Jun 8 808.962 [DR 8]
Jun 14 904.134 [DR 9]
Jun 19 1,010.489 [DR 10]
Jun 24 1,120.643 [DR 11]
Jun 28 1,206.714 [DR 12]
July 4 1,305.499 [DR 13]
July 14 1,414.609 [DR 14]
July 22 1,507.605 [DR 15]
July 28 1,601.249 [DR 16]
August 3 1,708.356 [DR 17]
August 10 1,808.092 [DR 18]
August 18 1,900.127 [DR 19]
August 26 2,003.914 [DR 20]

Vaccines

As of November 21, 2022, seven vaccines have been approved in mainland China through conditional marketing authorization or emergency use authorization.

In 2021 Nature reported that "studies have questioned the length of protection" that domestic vaccines such as CoronaVac and Sinopharm offer, especially when compared to mRNA vaccines.[19] A 2022 meta-analysis found about 65% vaccine effectiveness against infection for CoronoVac, compared with about 90% for Pfizer and 98% for Moderna.[20] Some analysts have criticized China's reluctance to import mRNA vaccines.[21]

Vaccine Type Made by Origin Dose required for vaccination Effective rate (Phase III) Approval Deployment WHO Listed
Sinopharm BIBP Inactivated Beijing Institute of Biological Products China 2 doses[22] 78.1%[23] Conditional
(December 31, 2020)[24] 		December 31, 2020 May 7, 2021
CoronaVac Inactivated Sinovac Biotech China 2 doses[22] 50.7% - 83.5%[25][26] Conditional
(February 5, 2021)[27] 		February 5, 2021 June 1, 2021
Sinopharm WIBP Inactivated Wuhan Institute of Biological Products China 2 doses[22] 72.8%[23] Conditional
(February 25, 2021)[28] 		February 25, 2021
KCONVAC Inactivated Kangtai Biological Products Co. Ltd. China 2 doses[22] — EUA
(May 14, 2021)[29] 		June 1, 2021
Covidful Inactivated Institute of Medical Biology, Chinese Academy of Medical Sciences China 2 doses[22] — EUA
(June 9, 2021)[30] 		June 9, 2021
Convidecia Viral vector CanSino China 1 dose[22] 65.7%[31] Conditional
(February 25, 2021)[32] 		February 25, 2021 May 19, 2022[33]
ZIFIVAX Subunit Zhifei Bio-tech China 3 doses[22] 82%[34][35] EUA
(March 10, 2021)[36] 		March 10, 2021

The Pfizer–BioNTech COVID-19 vaccine, agented by Fosun Pharma in mainland China, is waiting for approval.[37]

Vaccine Type Made by Origin Dose required for vaccination Effective rate (Phase III) Approval Deployment WHO Listed
Comirnaty mRNA BioNTech and Fosun Pharma Germany Waiting for Approval[37] December 31, 2020

See also



References

Daily reports on COVID-19 vaccination
  1. ^ National Health Commission (29 March 2021). "新冠病毒疫苗接种情况". Archived from the original on 30 March 2021. Retrieved 22 June 2021.
  2. ^ National Health Commission (22 April 2021). "新冠病毒疫苗接种情况".
  3. ^ National Health Commission (8 May 2021). "新冠病毒疫苗接种情况".
  4. ^ National Health Commission (17 May 2021). "新冠病毒疫苗接种情况".
  5. ^ National Health Commission (24 May 2021). "新冠病毒疫苗接种情况".
  6. ^ National Health Commission (29 May 2021). "新冠病毒疫苗接种情况". Archived from the original on 30 May 2021. Retrieved 22 June 2021.
  7. ^ National Health Commission (3 June 2021). "新冠病毒疫苗接种情况".
  8. ^ National Health Commission (9 June 2021). "新冠病毒疫苗接种情况".
  9. ^ National Health Commission (15 June 2021). "新冠病毒疫苗接种情况".
  10. ^ National Health Commission (20 June 2021). "新冠病毒疫苗接种情况".
  11. ^ National Health Commission (25 June 2021). "新冠病毒疫苗接种情况".
  12. ^ National Health Commission (29 June 2021). "新冠病毒疫苗接种情况". Archived from the original on 30 June 2021. Retrieved 31 August 2021.
  13. ^ National Health Commission (5 July 2021). "新冠病毒疫苗接种情况".
  14. ^ National Health Commission (15 July 2021). "新冠病毒疫苗接种情况". Archived from the original on 16 July 2021. Retrieved 31 August 2021.
  15. ^ National Health Commission (23 July 2021). "新冠病毒疫苗接种情况". Archived from the original on 24 July 2021. Retrieved 31 August 2021.
  16. ^ National Health Commission (29 July 2021). "新冠病毒疫苗接种情况".
  17. ^ National Health Commission (4 August 2021). "新冠病毒疫苗接种情况". Archived from the original on 5 August 2021. Retrieved 31 August 2021.
  18. ^ National Health Commission (11 August 2021). "新冠病毒疫苗接种情况". Archived from the original on 12 August 2021. Retrieved 31 August 2021.
  19. ^ National Health Commission (19 August 2021). "新冠病毒疫苗接种情况".
  20. ^ National Health Commission (27 August 2021). "新冠病毒疫苗接种情况".
News and Articles
  1. ^ a b c Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; Macdonald, Bobbie; Beltekian, Diana; Dattani, Saloni; Roser, Max (2020–2022). "Coronavirus Pandemic (COVID-19)". Our World in Data. Retrieved 30 June 2024.
  2. ^ Liu, Roxanne; Tian, Yew Lun (24 July 2022). "Two years after drive began, China reveals Xi Jinping received local COVID vaccine". The Age. Fairfax Media. Archived from the original on 24 July 2022. Retrieved 24 July 2022.
  3. ^ "中国于7月22日启动新冠疫苗紧急使用 接种人数超2万". Jiefang Daily. 23 August 2020. Archived from the original on 24 August 2020. Retrieved 2 April 2021.
  4. ^ a b 陈席元; 徐鹏航 (20 June 2021). "十亿来之不易，你我仍需努力". Xinhua News Agency. Archived from the original on 24 June 2021. Retrieved 23 June 2021.
  5. ^ a b "目前累计已完成100多万剂次新冠疫苗紧急接种 未出现严重不良反应". SCIO. 19 December 2020. Archived from the original on 2 May 2021. Retrieved 2 April 2021.
  6. ^ a b "中国首度正式批准新冠疫苗上市 大规模接种或将迅速展开". BBC.com. Archived from the original on 31 December 2020. Retrieved 31 December 2020.
  7. ^ "中国新冠疫苗全民免费提供，关于疫苗的最权威信息都在这". The Beijing News. Archived from the original on 12 January 2021. Retrieved 31 December 2020.
  8. ^ a b 彭韵佳 王琳琳 (27 January 2021). "目前我国已接种新冠疫苗2276.7万剂次". Xinhua News Agency. Archived from the original on 3 June 2021. Retrieved 22 June 2021.
  9. ^ "钟南山：中国疫苗接种率为3.56%，计划6月底达40%". Guancha.cn. Archived from the original on 23 April 2021. Retrieved 16 March 2021.
  10. ^ "孙春兰出席全国新冠病毒疫苗接种工作电视电话会议并讲话". Xinhua. 22 March 2021. Archived from the original on 24 March 2021. Retrieved 27 April 2021 – via the State Council.
  11. ^ "中国今起开始日报冠病疫苗接种数量". Lianhe Zaobao. 24 March 2021. Archived from the original on 24 April 2021. Retrieved 25 March 2021.
  12. ^ NHC Bureau of Disease Control and Prevention (29 March 2021). "新冠病毒疫苗接种技术指南（第一版）". National Health Commission. Retrieved 3 April 2021.
  13. ^ "全国新冠疫苗接种超2亿剂次". Chinanews.com. Archived from the original on 23 April 2021. Retrieved 23 April 2021.
  14. ^ "国家卫健委：5月至今新增境外输入确诊病例142例 必须加快推进新冠疫苗接种". People.com.cn. 14 May 2021. Archived from the original on 14 May 2021. Retrieved 14 May 2021.
  15. ^ "权威快报|全国新冠疫苗接种剂次超10亿". Xinhuanet.com. Xinhua News Agency. 20 June 2021. Archived from the original on 25 May 2022. Retrieved 22 June 2021.
  16. ^ a b "中国新冠病毒"清零"政策对习近平造成危险". BBC News 中文 (in Simplified Chinese). 9 July 2022. Archived from the original on 11 January 2023. Retrieved 9 November 2023.
  17. ^ 张曼玉 (10 February 2021). "全国累计报告接种新冠疫苗4052万剂次，现有本土确诊病例连续15天下降". China Youth Daily. Archived from the original on 28 June 2021. Retrieved 22 June 2021.
  18. ^ 彭韵佳 王琳琳 (15 March 2021). "我国新冠疫苗接种已达6498万人次". Xinhua News Agency. Archived from the original on 23 April 2021. Retrieved 22 June 2021.
  19. ^ Mallapaty, Smriti (14 October 2021). "China's COVID vaccines have been crucial — now immunity is waning". Nature. 598 (7881): 398–399. Bibcode:2021Natur.598..398M. doi:10.1038/d41586-021-02796-w. PMID 34650240. S2CID 238990258. Archived from the original on 30 November 2022. Retrieved 30 November 2022.
  20. ^ Zheng, Caifang; Shao, Weihao; Chen, Xiaorui; Zhang, Bowen; Wang, Gaili; Zhang, Weidong (January 2022). "Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis". International Journal of Infectious Diseases. 114: 252–260. doi:10.1016/j.ijid.2021.11.009. PMC 8595975. PMID 34800687. S2CID 244134232.
  21. ^ "Zero-Covid policy: why is China still having severe lockdowns?". the Guardian. 29 November 2022. Archived from the original on 29 November 2022. Retrieved 30 November 2022.
  22. ^ a b c d e f g "新冠病毒疫苗接种问答来了！涉及34个关键问题". Chinanews.com. 1 April 2021. Archived from the original on 5 May 2021. Retrieved 2 April 2021.
  23. ^ a b Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S. (26 May 2021). "Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial". JAMA. 326 (1): 35–45. doi:10.1001/jama.2021.8565. ISSN 0098-7484. PMC 8156175. PMID 34037666.
  24. ^ "大陸宣布首款新冠疫苗有條件上市 保護率近八成". UDN (in Traditional Chinese). 31 December 2020. Archived from the original on 28 June 2021. Retrieved 31 December 2020.
  25. ^ Tanriover, Mine Durusu; Doğanay, Hamdi Levent; Akova, Murat; Güner, Hatice Rahmet; Azap, Alpay; Akhan, Sıla; et al. (8 July 2021). "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey". The Lancet. 398 (10296): 213–222. doi:10.1016/S0140-6736(21)01429-X. ISSN 0140-6736. PMC 8266301. PMID 34246358.
  26. ^ Toscano, Cristiana (29 April 2021). "Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine" (PDF). World Health Organization (WHO). Archived (PDF) from the original on 13 July 2021. Retrieved 31 August 2021.
  27. ^ "China approves Sinovac vaccines for general public use". South China Morning Post. 6 February 2021. Archived from the original on 23 June 2021. Retrieved 23 June 2021.
  28. ^ "国家药监局附条件批准国药中生武汉公司新型冠状病毒灭活疫苗（Vero细胞）注册申请". National Medical Products Administration. 25 February 2021. Archived from the original on 2 March 2021. Retrieved 25 February 2021.
  29. ^ "深圳康泰生物新冠灭活疫苗被纳入紧急使用". Xinhuanet.com. 15 May 2021. Archived from the original on 15 May 2021. Retrieved 15 May 2021.
  30. ^ UDN (9 June 2021). "中國大陸再有一新冠病毒滅活疫苗上市使用". UDN (in Chinese (Taiwan)). Archived from the original on 10 June 2021. Retrieved 10 June 2021.
  31. ^ "CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says". Reuters. 8 February 2021. Archived from the original on 24 March 2021. Retrieved 8 February 2021.
  32. ^ "中国国家药监局附条件批准国药集团武汉和康希诺两公司新冠疫苗注册申请". Reuters. 6 February 2021. Archived from the original on 28 June 2021. Retrieved 23 June 2021.
  33. ^ "Who Validates 11TH Vaccine for COVID-19". WHO. 19 May 2022. Archived from the original on 19 May 2022. Retrieved 9 June 2022.
  34. ^ "New Chinese vaccine shows 82% effectiveness against serious Covid-19". The Straits Times. 27 August 2021. Archived from the original on 30 August 2021. Retrieved 30 August 2021.
  35. ^ "Chinese three-shot vaccine nearly 82 per cent effective, says maker". South China Morning Post. 28 August 2021. Archived from the original on 30 August 2021. Retrieved 30 August 2021.
  36. ^ "新冠疫苗｜智飛生物與中科院微生物所合作研發產品獲批緊急使用". HK01 (in Chinese (Hong Kong)). 16 March 2021. Archived from the original on 3 May 2021. Retrieved 3 April 2021.
  37. ^ a b "直击复星医药股东大会：mRNA新冠疫苗审批进展成焦点". National Business Daily. 12 June 2021. Archived from the original on 24 June 2021. Retrieved 23 June 2021.

External links

Wikimedia Commons has media related to COVID-19 vaccination in mainland China.
Read more information:

Galway

City in Connacht, Ireland This article is about the city in Ireland. For other uses, see Galway (disambiguation). City in Connacht, IrelandGalway GaillimhCityFrom top; left to right: Galway Cathedral, University of Galway, Eyre Square, Galway Harbour, the Long Walk Coat of armsNickname: City of the TribesMotto(s): Laudatio Ejus Manet In Secula Seculorum[1]  (Latin)His Praise Remains unto Ages of AgesGalwayLocation within IrelandShow map of IrelandGalwayLocation within…

Camerlengo (Chiesa cattolica)

Questa voce o sezione sull'argomento diritto canonico non cita le fonti necessarie o quelle presenti sono insufficienti. Puoi migliorare questa voce aggiungendo citazioni da fonti attendibili secondo le linee guida sull'uso delle fonti. Lo stemma del cardinale camerlengo (se arcivescovo) durante la sede vacante. Camerlengo è il titolo utilizzato nell'ordinamento della Chiesa cattolica per indicare alcune eminenti figure del clero. Il termine deriva dal latino medievale camarlingus, a sua v…

Lagu Kebangsaan RSS Moldavia

Имнул де Стат ал РСС МолдовенештьLagu kebangsaan RSS MoldaviaPenulis lirikEmilian Bukov, Bogdan IstruKomponisȘtefan Neaga (1945) Eduard Lazarev (Pembaruan 1980)Penggunaan1945 (Versi Asli) 1980 (Pembaruan)Pencabutan1980 (Versi Asli) 1991 (Pembaruan) Lagu Kebangsaan RSS Moldavia (vokal 1945)Lagu Kebangsaan RSS Moldavia (instrumental 1945)Lagu Kebangsaan Republik Sosialis Soviet Moldavia (bahasa Moldova: Имнул де Стат ал РСС Молдовенешть; bah…

Hijrat Laban

Hijrat LabanPermukimanHijrat LabanLocation in the Kingdom of Saudi ArabiaKoordinat: 24°38′N 46°43′E / 24.633°N 46.717°E / 24.633; 46.717Koordinat: 24°38′N 46°43′E / 24.633°N 46.717°E / 24.633; 46.717Negara Arab SaudiPemerintahan • Gubernur Pangeran RiyadhFaisal bin Bandar Al Saud • Wali kotaIbraheem Mohammed Al-SultanKetinggian612 m (2,008 ft)Zona waktuUTC+3 (AST) • Musim panas (DST…

John Rutsey

John RutseyInformasi latar belakangNama lahirJohn Howard RutseyLahir(1952-07-23)23 Juli 1952Meninggal11 Mei 2008(2008-05-11) (umur 55)TorontoGenreHard rock, heavy metalPekerjaanMusisiInstrumenDrum, perkusi, vokalTahun aktif1963–1974LabelMercury RecordsArtis terkaitRushSitus webwww.rush.com John Howard Rutsey (23 Juli 1952 – 11 Mei 2008) adalah seorang drummer Kanada, paling dikenal sebagai anggota pendiri Rush bersama dengan Alex Lifeson dan Jeff Jones, dan tampil di band debut album. J…

Baju kepok

Seseorang mengenakan baju kepok terlipat. Baju kepok, baju leher tinggi, atau baju leher panjang adalah pakaian — biasanya baju panas — dengan kerah pas yang dapat dilipat dan menutupi leher. Sejarah Eropa Pakaian baju kepok telah dipakai selama ratusan tahun, setidaknya sejak abad ke-15. Mereka awalnya dirancang untuk melindungi leher para ksatria yang memakai zirah rantai. Royalti mengadopsi busana leher tinggi, dengan tinggi dan volume kerutan leher yang menunjukkan status. […

Chūichi Nagumo

Chūichi NagumoLaksamana Madya Chuichi NagumoPengabdian Kekaisaran JepangDinas/cabangAngkatan Laut Kekaisaran JepangLama dinas1908-1944PangkatLaksamanaKesatuanKido ButaiKomandanKido Butai, Divisi I Kapal Induk, Armada Udara I, Armada III Angkatan Laut Kekaisaran Jepang, Distrik Angkatan Laut Sasebo, Distrik Angkatan Laut Kure, Armada I Angkatan Laut Jepang, Armada Kawasan Pasifik Tengah, Armada Udara 14 Angkatan Laut Kekaisaran Jepang[1]Perang/pertempuranPerang Dunia IIPertempuran S…

Jawa Sri Lanka

Artikel ini sebatang kara, artinya tidak ada artikel lain yang memiliki pranala balik ke halaman ini.Bantulah menambah pranala ke artikel ini dari artikel yang berhubungan atau coba peralatan pencari pranala.Tag ini diberikan pada Januari 2023. Artikel ini sebatang kara, artinya tidak ada artikel lain yang memiliki pranala balik ke halaman ini.Bantulah menambah pranala ke artikel ini dari artikel yang berhubungan atau coba peralatan pencari pranala.Tag ini diberikan pada Oktober 2022. Jawa Sri L…

Edward VIII dari Britania Raya

Raja Edward VIII dari Britania RayaKepala Persemakmuran Adipati WindsorPotret resmi, 1930anRaja Britania Raya dan Irlandia Utara Serta wilayah Alam Persemakmuran & Kaisar IndiaBerkuasa20 Januari 1936 – 11 Desember 1936(326 hari)PendahuluGeorge VPenerusGeorge VIPerdana Menteri Lihat daftar Joseph Aloysius LyonsWilliam Lyon Mackenzie KingÉamon de ValeraMichael Joseph SavageJames CraigJ. B. M. HertzogGodfrey HugginsStanley Baldwin Informasi pribadiKelahiranPangeran Edward dari York…

Cumbria

Ne doit pas être confondu avec Cambrie. Cumbria Administration Pays Royaume-Uni Nation Angleterre Région Angleterre du Nord-Ouest Statut Comté non métropolitainComté cérémonial Démographie Population 498 888 hab. (2019) Densité 74 hab./km2 Géographie Superficie 6 768 km2 modifier  Le comté de Cumbria (prononcé en anglais /ˈkʌm.bɹiə/, localement /ˈkʊm.bɹiə/) est un comté non métropolitain essentiellement rural du nord-ouest de l'Angleterre. Son …

Anne Consigny

Anne ConsignyConsigny, 2017Lahir25 Mei 1963 (umur 60)Alençon, Orne, Prancis[1]PekerjaanAktrisTahun aktif1981–sekarangSuami/istriÉric de Chassey ​(m. 2013)​Anak2 Anne Consigny (pengucapan bahasa Prancis: [an kɔ̃siɲi]; lahir 25 Mei 1963) adalah seorang aktris asal Prancis yang telah aktif sejak tahun 1981. Dia menerima nominasi César Award untuk Aktris Terbaik untuk perannya dalam film tersebut Not Here to Be Loved (2005). Dia juga dikena…

Élections cantonales de 1928 dans le Finistère

1925 1931 Élections cantonales de 1928 dans le Finistère Les 21 cantons de la série 1 du Finistère 14 octobre 1928 et 21 octobre 1928 Type d’élection Élections cantonales Conseil général après élection Conseil sortant SFIO : 3 sièges Rép.soc : 2 sièges Rad/Rad-Soc : 10 sièges Rép.rad : 1 siège Rép.G : 9 sièges URD: 10 sièges Conserv : 8 sièges Après élection SFIO : 3 sièges Rép.soc : 2 sièges Rad/Rad-soc : 9 sièges Ré…

Antoine de Saint-Exupéry

Antoine de Saint-ExupérySaint-Exupéry di Toulouse, 1933LahirAntoine Marie Jean-Baptiste Roger de Saint-Exupéry(1900-06-29)29 Juni 1900Lyon, PrancisMeninggal31 Juli 1944(1944-07-31) (umur 44)Pesisir pantai, selatan Marseilles, PrancisPekerjaanPenerbang, penulisKebangsaanPrancisPeriode1929-1948 (posthumous)GenreOtobiografi, Belles-Lettres, Cerita Anak-anakPasanganConsuelo Gómez Carillo de Saint-Exupéry, (1931-meninggal) Antoine de Saint-Exupéry (29 Juni 1900 – 31 Juli 19…

List of equipment of the United States Army during World War II

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: List of equipment of the United States Army during World War II – news · newspapers · books · scholar · JSTOR (December 2021) (Learn how and when to remove this template message) The following is a list of equipment of the United States Army during World War II wh…

Date

Pour les articles homonymes, voir Date (homonymie). Monument de fleurs au Keukenhof pour l'intronisation de Willem-Alexander, roi des Pays-Bas. La date est, au sens usuel, une indication de temps visant à définir un jour unique, généralement du calendrier grégorien. On l’utilise notamment pour repérer, avec l’heure, un événement temporel donné. Le calendrier grégorien, utilisé aujourd’hui par la plupart des pays européens, se base sur une année terrestre, c’est-à-dire une r…

Dassault Mirage III

Dassault Mirage IIIC Mirage IIIC de l'escadron de chasse 2/10 Seine en 1980 armé d'un Matra R530. Constructeur Dassault Aviation Rôle Avion de chasse Statut En service (au Pakistan)[1] Premier vol 12 juin 1956 Mise en service 1961 Date de retrait 1994 en France2015 en Argentine Nombre construits 870 Équipage 1 pilote Motorisation Moteur IIIC : Snecma Atar 9B, 6 000 kg de poussée IIIE : Snecma Atar 9C8, 66 685,22 N Nombre 1 Type Turboréacteur avec postcombustion…

Hippocampal formation

Region of the temporal lobe in mammalian brains Hippocampal formationThe hippocampal formation, as drawn by Santiago Ramon y Cajal: DG: dentate gyrus. Sub: subiculum. EC: entorhinal cortex. CA1-CA3: hippocampus properDetailsPart ofTemporal lobeIdentifiersLatinformatio hippocampiNeuroNames177NeuroLex IDbirnlex_7151FMA74038Anatomical terms of neuroanatomy[edit on Wikidata] The hippocampal formation is a compound structure in the medial temporal lobe of the brain. It forms a c-shaped bulge on t…

Yakovlev Yak-130

Yakovlev Yak-130 Un Yak-130 en 2012. Constructeur Yakovlev Rôle Avion d'entraînement, de reconnaissance et d'appui-feu Statut En service Premier vol 25 avril 1996 Équipage 2 Motorisation Moteur Ivtchenko-Progress AI-222 Nombre 2 Type Turboréacteur Poussée unitaire 2 500 kgp Dimensions Envergure 10,40 m Longueur 11,49 m Hauteur 4,76 m Surface alaire 23,52 m2 Masses À vide 4 600 kg Maximale 9 000 kg Performances Vitesse maximale 1 050…

Learjet

Manufacturer of business jets LearjetFounded1962[1]FounderBill LearDefunct2021FateAcquired by Bombardier Aerospace in 1990, production ceased in 2021HeadquartersWichita, KansasParentBombardier Aviation (1990–2021)SubsidiariesBrantly Helicopter Corporation (1966–1969) Learjet was a manufacturer of business jets for civilian and military use based in Wichita, Kansas, United States. Founded in the late 1950s by William Powell Lear as Swiss American Aviation Corporation, it became a subs…

Lakeboat (film)

2000 Canadian filmLakeboatDirected byJoe MantegnaWritten byDavid MametProduced byEric R. EppersonTony MametJoe MantegnaMorris RuskinStacia SekulerStarringCharles DurningPeter FalkDenis LearyAndy GarcíaRoberta AngelicaCinematographyPaul SarossyEdited byChristopher CibelliMusic byBob MametDistributed byOne Vibe EntertainmentRelease date 2000 (2000) Running time98 minutesCountriesCanadaUnited StatesLanguageEnglish Lakeboat is a 2000 American drama film, adapted by David Mamet from his 1970 pl…

Kembali kehalaman sebelumnya